Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4232529261
